Press Release: European Medicines Agency recommends limiting long-term use of calcitonin medicines

Author (Corporate)
Series Title
Series Details EMA/CHMP/483874/2012 (20.7.12)
Publication Date 20/07/2012
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), on 20 July 2012, recommended that calcitonin-containing medicines should only be used for short-term treatment, because of evidence that long-term use of these medicines is associated with an increased risk of cancer.

Source Link http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/07/news_detail_001573.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/CHMP/483874/2012 (20.7.12): European Medicines Agency recommends limiting long-term use of calcitonin medicines http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2012/07/WC500130122.pdf
Subject Categories
Countries / Regions